{"title":"The Correlation between Maternal and Neonatal Vit D (25(OH)D) Levels in Greece: A Cross-Sectional Study.","authors":"Artemisia Kokkinari, Maria Dagla, Evangelia Antoniou, Aikaterini Lykeridou, Giannoula Kyrkou, Kostas Bagianos, Georgios Iatrakis","doi":"10.3390/clinpract14030060","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Few studies have correlated maternal and neonatal Vit D (25(OH)D) levels at birth in Greece. We investigated this potential association, taking into account the administration or not of low doses (400-800 IU) of prenatal Vit D supplements. Our study contributes evidence not only to the small amount of existing literature regarding the above correlation, but also to the topic of maternal and neonatal vitamin D deficiency (VDD) during pregnancy in Mediterranean countries, such as Greece.</p><p><strong>Methods: </strong>A cross-sectional study was conducted on 248 neonates and their mothers from September 2019 to January 2022. Blood samples of 25(OH)D were studied at the time of delivery. Frequency counts and percentages were registered, and logistic regression was used to investigate the independent factors associated with maternal Vit D status. The Chi-square test and the Pearson coefficient were used to demonstrate a possible association between maternal and neonatal 25(OH)D levels.</p><p><strong>Results: </strong>Our findings show a high prevalence of VDD in Greek women and their newborns at birth. This was observed not only in women who did not receive Vit D supplements, but also in all the study groups, especially in the autumn and winter months. We observed that mothers who received low doses (400-800 IU) of prenatal Vit D supplements increased both their own 25(OH)D concentrations and those of their newborns; however, the latter did not seem to be completely covered by the prenatal administration of Vit D because, although their 25(OH)D concentrations increased, they never reached sufficient 25(OH)D levels, unlike their mothers who reached sufficient concentrations.</p><p><strong>Conclusions: </strong>Overall, this study highlights the strong association between maternal and neonatal 25(OH)D concentrations at the end of gestation. However, neonates tended to show even lower 25(OH)D concentrations relative to maternal 25(OH)D concentrations. The same phenomenon was observed irrespective of the administration of Vit D supplements during pregnancy. Moreover, this is what was observed concerning the administration of formulations with 400-800 IU of Vit D, which the doctors in our clinic used in the present study. In any case, more clinical studies related to the administration of higher doses of Vit D supplementation to pregnant women would lead to more reliable conclusions. Without a doubt, the measurement of maternal vitamin D status during pregnancy provides opportunities for preventive and therapeutic interventions in the mother-infant pair.</p>","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"14 3","pages":"749-764"},"PeriodicalIF":1.7000,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11130881/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/clinpract14030060","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Few studies have correlated maternal and neonatal Vit D (25(OH)D) levels at birth in Greece. We investigated this potential association, taking into account the administration or not of low doses (400-800 IU) of prenatal Vit D supplements. Our study contributes evidence not only to the small amount of existing literature regarding the above correlation, but also to the topic of maternal and neonatal vitamin D deficiency (VDD) during pregnancy in Mediterranean countries, such as Greece.
Methods: A cross-sectional study was conducted on 248 neonates and their mothers from September 2019 to January 2022. Blood samples of 25(OH)D were studied at the time of delivery. Frequency counts and percentages were registered, and logistic regression was used to investigate the independent factors associated with maternal Vit D status. The Chi-square test and the Pearson coefficient were used to demonstrate a possible association between maternal and neonatal 25(OH)D levels.
Results: Our findings show a high prevalence of VDD in Greek women and their newborns at birth. This was observed not only in women who did not receive Vit D supplements, but also in all the study groups, especially in the autumn and winter months. We observed that mothers who received low doses (400-800 IU) of prenatal Vit D supplements increased both their own 25(OH)D concentrations and those of their newborns; however, the latter did not seem to be completely covered by the prenatal administration of Vit D because, although their 25(OH)D concentrations increased, they never reached sufficient 25(OH)D levels, unlike their mothers who reached sufficient concentrations.
Conclusions: Overall, this study highlights the strong association between maternal and neonatal 25(OH)D concentrations at the end of gestation. However, neonates tended to show even lower 25(OH)D concentrations relative to maternal 25(OH)D concentrations. The same phenomenon was observed irrespective of the administration of Vit D supplements during pregnancy. Moreover, this is what was observed concerning the administration of formulations with 400-800 IU of Vit D, which the doctors in our clinic used in the present study. In any case, more clinical studies related to the administration of higher doses of Vit D supplementation to pregnant women would lead to more reliable conclusions. Without a doubt, the measurement of maternal vitamin D status during pregnancy provides opportunities for preventive and therapeutic interventions in the mother-infant pair.
背景:在希腊,很少有研究将产妇和新生儿出生时的维生素 D (25(OH)D) 水平联系起来。考虑到是否服用低剂量(400-800 IU)产前维生素 D 补充剂,我们对这种潜在的关联性进行了调查。我们的研究不仅为有关上述相关性的少量现有文献提供了证据,也为希腊等地中海国家孕期母体和新生儿维生素 D 缺乏症(VDD)这一主题提供了证据:方法:2019 年 9 月至 2022 年 1 月期间,对 248 名新生儿及其母亲进行了横断面研究。对分娩时的 25(OH)D 血液样本进行了研究。对频率计数和百分比进行了登记,并使用逻辑回归法调查了与产妇维生素 D 状态相关的独立因素。利用卡方检验(Chi-square test)和皮尔逊系数(Pearson coefficient)来证明产妇和新生儿 25(OH)D 水平之间可能存在的关联:我们的研究结果表明,希腊妇女及其新生儿在出生时患有 VDD 的比例很高。这种情况不仅出现在未服用维生素 D 补充剂的妇女中,也出现在所有研究组中,尤其是在秋冬季节。我们观察到,接受低剂量(400-800 IU)产前维生素 D 补充剂的母亲提高了自身和新生儿的 25(OH)D 浓度;但是,产前维生素 D 的补充似乎并没有完全覆盖新生儿,因为虽然新生儿的 25(OH)D 浓度提高了,但他们从未达到足够的 25(OH)D 水平,而他们的母亲则达到了足够的浓度:总之,这项研究强调了妊娠末期母体和新生儿 25(OH)D 浓度之间的密切联系。然而,相对于母体的 25(OH)D 浓度,新生儿的 25(OH)D 浓度往往更低。无论孕期是否服用维生素 D 补充剂,都观察到了同样的现象。此外,在服用 400-800 IU 的维生素 D 制剂时也观察到了这种现象,我们诊所的医生在本研究中使用的就是这种制剂。无论如何,对孕妇服用更高剂量的维生素 D 补充剂进行更多的临床研究会得出更可靠的结论。毫无疑问,对孕期母体维生素 D 状态的测量为母婴双方的预防和治疗干预提供了机会。